BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 34525921)

  • 1. Nanocarriers as Administration Systems of Natural Products.
    Solís-Cruz GY; Pérez-López LA; Alvarez-Roman R; Rivas-Galindo VM; Silva-Mares DA; Ibarra-Rivera TR
    Curr Top Med Chem; 2021; 21(26):2365-2373. PubMed ID: 34525921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of nanocarriers for natural products.
    Huang L; Luo S; Tong S; Lv Z; Wu J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(3):e1967. PubMed ID: 38757428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomedical Applications of Multifunctional Polymeric Nanocarriers: A Review of Current Literature.
    Karabasz A; Bzowska M; Szczepanowicz K
    Int J Nanomedicine; 2020; 15():8673-8696. PubMed ID: 33192061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward the next-generation phyto-nanomedicines: cell-derived nanovesicles (CDNs) for natural product delivery.
    Chen C; Wang J; Sun M; Li J; Wang HD
    Biomed Pharmacother; 2022 Jan; 145():112416. PubMed ID: 34781147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nano based drug delivery systems: recent developments and future prospects.
    Patra JK; Das G; Fraceto LF; Campos EVR; Rodriguez-Torres MDP; Acosta-Torres LS; Diaz-Torres LA; Grillo R; Swamy MK; Sharma S; Habtemariam S; Shin HS
    J Nanobiotechnology; 2018 Sep; 16(1):71. PubMed ID: 30231877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug Delivery Systems of Natural Products in Oncology.
    Colone M; Calcabrini A; Stringaro A
    Molecules; 2020 Oct; 25(19):. PubMed ID: 33036240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic nanocarriers for intracellular protein delivery.
    Du J; Jin J; Yan M; Lu Y
    Curr Drug Metab; 2012 Jan; 13(1):82-92. PubMed ID: 22292811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High drug-loading nanomedicines: progress, current status, and prospects.
    Shen S; Wu Y; Liu Y; Wu D
    Int J Nanomedicine; 2017; 12():4085-4109. PubMed ID: 28615938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospects of Nanocarriers for Oral Delivery of Bioactives Using Targeting Strategies.
    Parayath NN; Nehoff H; Taurin S; Greish K
    Curr Pharm Biotechnol; 2016; 17(8):683-99. PubMed ID: 27033507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macromolecule nanotherapeutics: approaches and challenges.
    Tyagi P; Santos JL
    Drug Discov Today; 2018 May; 23(5):1053-1061. PubMed ID: 29326081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic core-shell systems as soft drug delivery nanocarriers.
    Lukowiak MC; Thota BN; Haag R
    Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1327-41. PubMed ID: 25868804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomedicine as a Strategy for Natural Compound Delivery to Prevent and Treat Cancers.
    Aljuffali IA; Fang CL; Chen CH; Fang JY
    Curr Pharm Des; 2016; 22(27):4219-31. PubMed ID: 27323758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-Installed Nanocarriers toward Precision Therapy.
    Mi P; Cabral H; Kataoka K
    Adv Mater; 2020 Apr; 32(13):e1902604. PubMed ID: 31353770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Insights into Effective Nanomaterials and Biomacromolecules Conjugation in Advanced Drug Targeting.
    Azandaryani AH; Kashanian S; Jamshidnejad-Tosaramandani T
    Curr Pharm Biotechnol; 2019; 20(7):526-541. PubMed ID: 31038063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro toxicity assessment of oral nanocarriers.
    Ciappellano SG; Tedesco E; Venturini M; Benetti F
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt B):381-401. PubMed ID: 27544694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanocarriers for pulmonary administration of peptides and therapeutic proteins.
    Andrade F; Videira M; Ferreira D; Sarmento B
    Nanomedicine (Lond); 2011 Jan; 6(1):123-41. PubMed ID: 21182424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifunctional nanoplatforms co-delivering combinatorial dual-drug for eliminating cancer multidrug resistance.
    Wei X; Song M; Li W; Huang J; Yang G; Wang Y
    Theranostics; 2021; 11(13):6334-6354. PubMed ID: 33995661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The acceptability of nanocarriers for drug delivery in different contexts of use: perceptions of researchers and research trainees in the field of new technologies.
    Chenel V; Boissy P; Poirier MS; Cloarec JP; Patenaude J
    Int J Nanomedicine; 2015; 10():2125-37; quiz 2138-9. PubMed ID: 25844040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationally designed DNA-based nanocarriers.
    Jiang Q; Zhao S; Liu J; Song L; Wang ZG; Ding B
    Adv Drug Deliv Rev; 2019 Jul; 147():2-21. PubMed ID: 30769047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhalative pharmacotherapy in the future--nanocarriers for pulmonary drug delivery].
    Gessler T
    Pneumologie; 2009 Dec; 63 Suppl 2():S113-6. PubMed ID: 20013540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.